Back to search results

Venetoclax to Augment Epigenetic Modification and Chemotherapy

Abroad (travel likely)RecruitingPHASE1

Conditions

Acute Myeloid Leukemia, in Relapse · Acute Myeloid Leukemia Refractory

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Children's Wisconsin, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Amberley Kemic, RN) · akemic@childrenswi.org · 414-266-2038
    Study coordinator · MACCcto@mcw.edu
    Contact: Principal Investigator (Michael Burke, MD)
    Zachary T. Graff, MD (Sub-investigator)
Study leads

  • Michael Burke, MD

    Study Chair

    Medical College of Wisconsin

View source on ClinicalTrials.gov(opens in a new tab)